Status:
UNKNOWN
Vacuolar ATPase and Drug Resistance of High Grade Gliomas
Lead Sponsor:
University of Milano Bicocca
Conditions:
Glioblastoma Multiforme
Eligibility:
All Genders
18-90 years
Brief Summary
GBMs are still considered tumors with few available treatment options that are able only to achieve a temporary local control of the disease. In case of a GBM, tumor recurrence is generally expected w...
Detailed Description
GBMs are still considered tumors with few available treatment options that are able only to achieve a temporary local control of the disease. In case of a GBM, tumor recurrence is generally expected w...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients =\> 18 years old;
- Patients with an intra-axial brain tumor suspect for glioma;
- Patients able to sign a consent form for research purpose;
- Patients with planned craniotomy for brain tumor resection.
- Exclusion Criteria
- Patients \< 18 years old;
- Patients with known brain tumors different than gliomas;
- Patients unable to sign a consent form for research purpose;
- Patients undergoing brain tumor biopsy;
- Patients with poor intra-operative or small surgical sample for histopathological diagnosis;
- Histology diagnostic for tumors different than gliomas.
Exclusion
Key Trial Info
Start Date :
January 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05328089
Start Date
January 30 2020
End Date
April 1 2024
Last Update
January 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Socio Sanitaria Territoriale Monza - Ospedale San Gerardo
Monza, Italy, 20900